Marijuana legalisation in the United States: An Australian perspective

Abstract

More than 20 US states have legalised the medicinal use of marijuana; in the past three years, four have also legalised its recreational use. At the same time, marijuana remains illegal under US federal law.This paper reviews the US experience to identify any potential lessons or hazards likely to emerge. It outlines the regulatory requirements of different US states for managing medicinal and recreational marijuana use, and the costs and benefits of these measures. It also critically analyses the most common commercial for-profit production and distribution model and examines the implications of this approach in terms of individual, social and criminological outcomes.

References

URLs current as at October 2024

Adler JH 2015. Marijuana, federal power and the states. Case Western Reserve Law Review 65(3): 505–512

Anderson DM, Hanson B & Rees DJ 2013. Medical marijuana laws, traffic fatalities and alcohol consumption. Journal of Law Economics 56: 333–369

Anderson DM, Rees DI & Sabia JJ 2014. Medical marijuana laws and suicides by gender and age. American Journal of Public Health 104: 2369–2376

Asbridge M, Hayden JA & Cartwright JL 2012. Acute cannabis consumption and motor vehicle collision risk: Systematic review of observational studies and meta-analysis. British Medical Journal 344

Babor T 2010. Alcohol: No ordinary commodity: research and public policy (2nd ed). Oxford: Oxford University Press

Barry RA, Hiilamo H & Glantz SA 2014. Waiting for the opportune moment: Tobacco industry and marijuana legalisation. The Millbank Quarterly 92(2): 207–242

Caulkins JP & Bond BM 2012. Marijuana price gradients: Implications for exports and export-generated tax revenue for California after legalisation. Journal of Drug Issues 42(1): 28–45

Caulkins JP, Hawken A, Kilmer B & Kleiman MR 2012. Marijuana legalisation: What everyone needs to know. Oxford: Oxford University Press

Caulkins JP et al. 2015a. Considering marijuana legalisation. Insights for Vermont and other jurisdictions. Rand Research Report 864. Santa Monica: Rand Corporation

Caulkins JP et al. 2015b. Options and issues regarding marijuana legalisation: Perspective. Santa Monica: Rand Corporation

Caulkins JP, Kilmer B & Kleiman MAR 2016 Marijuana legislation: What everyone needs to know. Second Edition. New York: Oxford University Press

Choo ek, Benz M, Zaller N, Warren O, Rising KL and McConnell KJ 2014. The impact of state medical marijuana legislation on adolescent marijuana use. Journal of Adolescent Health. 55: 160-166

Choi A 2014. The impact of medical marijuana laws on marijuana use and other risky health behaviours.

Colorado Department of Revenue 2016. Colorado marijuana tax data, https://cdor.colorado.gov/data-and-reports/income-tax-data

Couper FJ and Peterson BL 2014. The prevalence of marijuana in suspected impaired driving cases in Washington State. Journal of Analytical Toxicology. 38: 569-574

D’Amico EJ, Miles JNV and Tucker JS 2015. Gateway to curiosity: medical marijuana ads and intention and use during middle school. Psychology of Addictive Behaviours. 29(3):613-9

Denver Post, 3 November 2015. https://www.denverpost.com/2015/11/03/colorado-allowed-to-spend-marijuana-tax-money-as-voters-reject-refunds/

Friese B and Grube JW 2013. Legalisation of medical marijuana and marijuana use among youths. Drugs: education, prevention and policy. 20(1): 33–39

Gettman J & Kennedy M 2014. Let it grow – the open market solution to marijuana control. Harm Reduction Journal 11(32): 1–9

Harper S, Strumpf EC & Kaufman JS 2012. Do medical laws increase marijuana use? Replication study and extension. Annals of Epidemiology 22: 207–212

Hasin DS et al. 2015. Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: Results from annual, repeated cross-sectional surveys. Lancet Psychiatry 2: 601–608

Hall W & Degenhardt L 2009. Adverse health effects of non-medical cannabis use. Lancet 374: 1383–1391

Hall W & Weier M 2015. Assessing the Public Health Impacts of Legalising Recreational Cannabis Use in the USA. Clinical Pharmacology and Therapeutics 97(6); 607–615

Joffe A& Yancy WS 2004. Legalisation of marijuana: Potential impact on youth. Pediatrics 113(6): 632–638

Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE & Miech RA 2014. Monitoring the future: National survey results on drug use, 1975–2013: Volume 1, Secondary school students. Ann Arbor: Institute for Social Research, University of Michigan

Kilmer B, Caulkins JP, Pacula RL, MacCoun RJ & Reuter PH 2010. Altered State? Assessing How Marijuana Legalisation in California Could Influence Marijuana Consumption and Public Budgets. Occasional Paper. Santa Monica: The RAND Corporation

Kleiman MAR 2014. How not to make a hash out of cannabis legalisation. Washington Monthly. March/April/May: 32–37

Lynne-Landsman SD, Livingston MD & Wagenaar AC 2013. American Journal of Public Health 103(8): 1500–1506

MacCoun RJ 2011. What can we learn from the Dutch cannabis coffee shop system? Addiction 106: 1899–1910

MacCoun RJ & Mello MM 2015. Half-baked: The retail promotion of marijuana edibles. New England Journal of Medicine 2015: 372:989–991. https://www.nejm.org/doi/10.1056/NEJMp1416014

Miech RA et al. 2015. Trends in use of marijuana and attitudes toward marijuana among youth before and after decriminalisation: The case of California 2007–2013. International Journal of Drug Policy 26: 336–344

Musto DF 1987. The American Disease. Origins of narcotic control. Oxford: Oxford University Press

NSW Legislative Council 2013. The use of cannabis for medical purposes. Report 27. Sydney: Parliament of New South Wales

O’Connell TJ & Bou-Matar CB 2007. Long term marijuana users seeking medical cannabis in California (2001–07): Demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants. Harm Reduction Journal 4(16): 4–16

Pacula RL, Chriqui JF, Reichmann DA & Terry-McElrath Y 2002. State medical marijuana laws: understanding the laws and their limitations. Journal of Public Health Policy 23(4): 413–439.

Pacula R and Kilmer B 2014. Legalising cannabis is more than just a yes or no decision. The Conversation 1 May 2014. https://theconversation.com/legalising-cannabis-is-more-than-just-a-yes-or-no-decision-26124

Pacula RL et al. 2014. Developing public health regulations for marijuana: lessons from alcohol and tobacco. American Journal of Public Health 104(6) 1021–1028

Pacula RL, Powell D, Heaton P & Sevigny EL 2015. Assessing the effects of medical marijuana laws on marijuana use: The devil is in the details. Journal of Policy Analysis and Management 34(1): 7–31

Pardo B 2014. Cannabis policy reforms in the Americas: a comparative analysis of Colorado, Washington and Uruguay. International Journal of Drug Policy 25: 727–735.

Pawson R and Tilley N 1997. Realistic Evaluation. London: Sage

Ramaekers JG, Berghaus G, van Laar M and Drummer O 2004. Dose related risk of motor vehicle crashes after cannabis use. Drug and Alcohol Dependence 73: 109–119.

Room R, Fischer B, Hall WD, Lenton S & Reuter P 2010. Cannabis policy: Moving beyond stalemate. Oxford: Oxford University Press.

Room R 2014. Legalisaing a market for pleasure: Colorado, Washington, Uruguay and beyond. Addiction 109: 345–351

Thurstone C, Lieberman SA & Scmiege SJ 2011. Medical marijuana diversion and associated problems in adolescent treatment. Drug and Alcohol Dependence 118: 489492

United Nations Office on Drugs and Crime (UNODC) 2013. The International Drug Control Conventions. NY: United Nations

US Library of Congress 2014. Marijuana and the Controlled Substances Act: Federal marijuana penalties and state developments. Congressional Digest October 2014.

Wen H, Hockenberry JM & Cummings JR 2014. The effect of medical marijuana laws on adolescents and adult use of marijuana, alcohol and other substances. Journal of Health Economics 42: 64–80

Winstock AR, Lea T & Sheridan J 2008. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia. International Journal of Drug Policy 19(6): 450–458